266 related articles for article (PubMed ID: 27481036)
21. Differences of the Fecal Microflora With Clostridium difficile Therapies.
Louie TJ; Byrne B; Emery J; Ward L; Krulicki W; Nguyen D; Wu K; Cannon K
Clin Infect Dis; 2015 May; 60 Suppl 2():S91-7. PubMed ID: 25922407
[TBL] [Abstract][Full Text] [Related]
22. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
23. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
[TBL] [Abstract][Full Text] [Related]
24. Whole-genome sequencing improves discrimination of relapse from reinfection and identifies transmission events among patients with recurrent Clostridium difficile infections.
Mac Aogáin M; Moloney G; Kilkenny S; Kelleher M; Kelleghan M; Boyle B; Rogers TR
J Hosp Infect; 2015 Jun; 90(2):108-16. PubMed ID: 25935700
[TBL] [Abstract][Full Text] [Related]
25. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
McDonald EG; Milligan J; Frenette C; Lee TC
JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients.
Messick CA; Hammel JP; Hull T
Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570
[TBL] [Abstract][Full Text] [Related]
27. Recurrent Clostridium difficile infection is associated with increased mortality.
Olsen MA; Yan Y; Reske KA; Zilberberg MD; Dubberke ER
Clin Microbiol Infect; 2015 Feb; 21(2):164-70. PubMed ID: 25658560
[TBL] [Abstract][Full Text] [Related]
28. Gut metabolites predict Clostridioides difficile recurrence.
Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
[TBL] [Abstract][Full Text] [Related]
29. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis.
Oshima T; Wu L; Li M; Fukui H; Watari J; Miwa H
J Gastroenterol; 2018 Jan; 53(1):84-94. PubMed ID: 28744822
[TBL] [Abstract][Full Text] [Related]
30. Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies.
De Wolfe TJ; Kates AE; Barko L; Darien BJ; Safdar N
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988143
[TBL] [Abstract][Full Text] [Related]
31. Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment.
Pakpour S; Bhanvadia A; Zhu R; Amarnani A; Gibbons SM; Gurry T; Alm EJ; Martello LA
Microbiome; 2017 Nov; 5(1):148. PubMed ID: 29132405
[TBL] [Abstract][Full Text] [Related]
32. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy.
Bouza E; Alcalá L; Marín M; Valerio M; Reigadas E; Muñoz P; González-Del Vecchio M; de Egea V
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1777-1786. PubMed ID: 28501926
[TBL] [Abstract][Full Text] [Related]
33. Microbiologic factors affecting Clostridium difficile recurrence.
Chilton CH; Pickering DS; Freeman J
Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of dual-strain Clostridium difficile infection in an in vitro human gut model.
Crowther GS; Chilton CH; Todhunter SL; Nicholson S; Freeman J; Wilcox MH
J Antimicrob Chemother; 2015 Aug; 70(8):2316-21. PubMed ID: 25925596
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection.
Hirsch BE; Saraiya N; Poeth K; Schwartz RM; Epstein ME; Honig G
BMC Infect Dis; 2015 Apr; 15():191. PubMed ID: 25885020
[TBL] [Abstract][Full Text] [Related]
36. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk.
Davis MY; Zhang H; Brannan LE; Carman RJ; Boone JH
Microbiome; 2016 Oct; 4(1):53. PubMed ID: 27717398
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.
Milani C; Ticinesi A; Gerritsen J; Nouvenne A; Lugli GA; Mancabelli L; Turroni F; Duranti S; Mangifesta M; Viappiani A; Ferrario C; Maggio M; Lauretani F; De Vos W; van Sinderen D; Meschi T; Ventura M
Sci Rep; 2016 May; 6():25945. PubMed ID: 27166072
[TBL] [Abstract][Full Text] [Related]
38. Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings.
Appaneal HJ; Caffrey AR; Beganovic M; Avramovic S; LaPlante KL
Am J Health Syst Pharm; 2019 Apr; 76(9):581-590. PubMed ID: 31361830
[TBL] [Abstract][Full Text] [Related]
39. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
Rodrigues R; Barber GE; Ananthakrishnan AN
Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
